Website for Adolescents About Pediatric Clinical Trials

Adolescents will be asked to respond to 6 questions that assess their positive attitudes about clinical trials (e.g., How do you feel about teens participating in clinical trials?; 1=Not good at all; 2=Not very good; 3=Not sure; 4=Good; 5=Very good). Responses will be averaged and the minimum scale score is 1 and the maximum scale score is 5. Higher scores indicate more positive attitudes toward clinical trials.

Time frame: Baseline and Week 1

Population: The discrepancy between the overall number of participants analyzed and participant flow is due to imputation. Demographic variables were not imputed so if a participant was missing demographic data, they were not included in the outcome analyses.

Adolescents will be asked to respond to 5 questions about their beliefs about pediatric clinical research (e.g., I believe that clinical trials can help teens; 1=Strongly Disagree; 2=Disagree; 3=Unsure; 4=Agree; 5=Strongly Agree). Responses will be averaged and the minimum scale score is 1 and the maximum scale score is 5. Higher scores indicate more positive beliefs about clinical trials.

Time frame: Baseline and Week 1

Population: The discrepancy between the overall number of participants analyzed and participant flow is due to imputation. Demographic variables were not imputed so if a participant was missing demographic data, they were not included in the outcome analyses.

Adolescents will be asked to respond to 3 questions about their confidence in participating clinical trials (e.g., I know what rights I have in a clinical trial.; 1=Strongly Disagree; 2=Disagree; 3=Unsure; 4=Agree; 5=Strongly Agree). Responses will be averaged and the minimum scale score is 1 and the maximum scale score is 5. Higher scores indicate more confidence in participating in clinical trials.

Time frame: Baseline and Week 1

Population: The discrepancy between the overall number of participants analyzed and participant flow is due to imputation. Demographic variables were not imputed so if a participant was missing demographic data, they were not included in the outcome analyses.

Adolescents will be asked to respond to one question about their familiarity with clinical trials \[How much do you know about pediatric clinical trials (research studies with children under 18; 1 = I don't know anything; 2 = I know a little about them; 3 = I know some things about them; 4 = I know a lot about them; 5 = I know all there is to know about them\]. Responses will be averaged and the minimum scale score is 1 and the maximum scale score is 5. Higher scores indicate greater familiarity with pediatric clinical trials.

Time frame: Baseline and Week 1

Population: The discrepancy between the overall number of participants analyzed and participant flow is due to imputation. Demographic variables were not imputed so if a participant was missing demographic data, they were not included in the outcome analyses.

Adolescents will respond to 27 questions that assess their factual knowledge about clinical research (e.g., Which is true of a behavioral treatment trial?). Questions are in multiple choice format (some questions have multiple correct answers), and the total score could range from 0-53 correct. Higher scores indicate more knowledge about clinical research.

Time frame: Baseline and Week 1

Population: The discrepancy between the overall number of participants analyzed and participant flow is due to imputation. Demographic variables were not imputed so if a participant was missing demographic data, they were not included in the outcome analyses.

Adolescents will be asked to respond to one question about the likelihood of their fear preventing them from participating in a clinical trial (i.e., How likely is it that your fearful or anxious feelings could stop you from participating in a clinical trial in the future?; 1 = Not likely; 2 = Somewhat likely; 3 = Moderately likely; 4 = Very likely; 5 = Extremely likely). Responses will be averaged and the minimum scale score is 1 and the maximum scale score is 5. Higher scores indicate greater likelihood of fear preventing participation in a clinical trial.

Time frame: Baseline and Week 1

Population: The discrepancy between the overall number of participants analyzed and participant flow is due to imputation. Demographic variables were not imputed so if a participant was missing demographic data, they were not included in the outcome analyses.

Adolescents will be asked to respond to one question about the likelihood of participating in a clinical trial (i.e., If you were asked to be in a clinical trial, how likely would you be to participate?; 1 = Not likely at all; 2 = Not very likely; 3 = Not sure; 4 = Likely; 5 = Very likely). Responses will be averaged and the minimum scale score is 1 and the maximum scale score is 5. Higher scores indicate greater likelihood of participation in a clinical trial.

Time frame: Baseline and Week 1

Population: The discrepancy between the overall number of participants analyzed and participant flow is due to imputation. Demographic variables were not imputed so if a participant was missing demographic data, they were not included in the outcome analyses.

Adolescents will be asked to respond to 8 questions related to their perceptions of their relationship quality and communication with their parents (e.g., My parent gives me good advice; 1 = Strongly disagree; 2 = Disagree; 3 = Agree; 4 = Strongly agree). Responses will be averaged and the minimum scale score is 1 and the maximum scale score is 4. Higher scores indicate more positive perceptions of relationship quality.

Time frame: Baseline and Week 1

Population: The discrepancy between the overall number of participants analyzed and participant flow is due to imputation. Demographic variables were not imputed so if a participant was missing demographic data, they were not included in the outcome analyses.

Adolescents will be asked to respond to 4 questions related to their perceptions of fear or anxiety about different types of medical procedures, including getting a needle in the arm, injection in the leg, getting a scan, and taking new medicine (1 = Not at all afraid or anxious, 2 = Somewhat afraid or anxious, 3 = Moderately afraid or anxious, 4 = Very afraid or anxious, 5 = Extremely afraid or anxious). Responses will be averaged and the minimum scale score is 1 and the maximum scale score is 5. Higher scores indicate more fear about procedures.

Time frame: Baseline and Week 1

Population: The discrepancy between the overall number of participants analyzed and participant flow is due to imputation. Demographic variables were not imputed so if a participant was missing demographic data, they were not included in the outcome analyses.

Adolescents will be asked to respond to 10 questions about their self-efficacy for making decisions about clinical trial participation specific to communicating about clinical trials (e.g., Tell a doctor or researcher if I want to stop the clinical trial; 1 = I cannot do it at all; 5 = I know I can do it.) Responses will be averaged and the minimum scale score is 1 and the maximum scale score is 5. Higher scores indicate more self-efficacy about communication.

Time frame: Baseline and Week 1

Population: The discrepancy between the overall number of participants analyzed and participant flow is due to imputation. Demographic variables were not imputed so if a participant was missing demographic data, they were not included in the outcome analyses.

Adolescents will be asked to respond to 9 questions about their self-efficacy for making decisions about clinical trial participation specific to gathering information about clinical trials (e.g., Ask a doctor or researcher questions for more information about clinical trials; 1 = I cannot do it at all; 5 = I know I can do it.) Responses will be averaged and the minimum scale score is 1 and the maximum scale score is 5. Higher scores indicate more self-efficacy about gathering information.

Time frame: Baseline and Week 1

Population: The discrepancy between the overall number of participants analyzed and participant flow is due to imputation. Demographic variables were not imputed so if a participant was missing demographic data, they were not included in the outcome analyses.

Adolescents will review five research protocols related to a fictitious disease ('meditis') and respond to a question about their willingness to participate in each research study (e.g., If you had meditis, would you agree to enroll in this study?; 1 = Definitely not to 7 = Definitely yes). Responses will be averaged across the five protocols and the minimum scale score is 1 and the maximum scale score is 7. Higher scores indicate greater willingness to participate in the research studies.

Time frame: Baseline and Week 1

Population: The discrepancy between the overall number of participants analyzed and participant flow is due to imputation. Demographic variables were not imputed so if a participant was missing demographic data, they were not included in the outcome analyses.

Parents will be asked to respond to 6 questions that assess their positive attitudes about clinical trials (e.g., How do you feel about teens participating in clinical trials?; 1=Not good at all; 2=Not very good; 3=Not sure; 4=Good; 5=Very good). Responses will be averaged and the minimum scale score is 1 and the maximum scale score is 5. Higher scores indicate more positive attitudes toward clinical trials.

Time frame: Baseline and Week 1

Population: The discrepancy between the overall number of participants analyzed and participant flow is due to imputation. Demographic variables were not imputed so if a participant was missing demographic data, they were not included in the outcome analyses.

Parents will be asked to respond to 5 questions about their beliefs about pediatric clinical research (e.g., I believe that clinical trials can help teens; 1=Strongly Disagree; 2=Disagree; 3=Unsure; 4=Agree; 5=Strongly Agree). Responses will be averaged and the minimum scale score is 1 and the maximum scale score is 5. Higher scores indicate more positive beliefs about clinical trials.

Time frame: Baseline and Week 1

Population: The discrepancy between the overall number of participants analyzed and participant flow is due to imputation. Demographic variables were not imputed so if a participant was missing demographic data, they were not included in the outcome analyses.

Parents will be asked to respond to one question about their familiarity with clinical trials \[How much do you know about pediatric clinical trials (research studies with children under 18; 1 = I don't know anything; 2 = I know a little about them; 3 = I know some things about them; 4 = I know a lot about them; 5 = I know all there is to know about them\]. Responses will be averaged and the minimum scale score is 1 and the maximum scale score is 5. Higher scores indicate greater familiarity with pediatric clinical trials.

Time frame: Baseline and Week 1

Population: The discrepancy between the overall number of participants analyzed and participant flow is due to imputation. Demographic variables were not imputed so if a participant was missing demographic data, they were not included in the outcome analyses.

Parents will be asked to respond to one question about the likelihood of their fear preventing them from allowing their child to participate in a clinical trial (i.e., How likely is it that your fearful or anxious feelings could stop you from allowing your child to participate in a clinical trial in the future?; 1 = Not likely; 2 = Somewhat likely; 3 = Moderately likely; 4 = Very likely; 5 = Extremely likely). Responses will be averaged and the minimum scale score is 1 and the maximum scale score is 5. Higher scores indicate greater likelihood of fear preventing participation in a clinical trial.

Time frame: Baseline and Week 1

Population: The discrepancy between the overall number of participants analyzed and participant flow is due to imputation. Demographic variables were not imputed so if a participant was missing demographic data, they were not included in the outcome analyses.

Parents will be asked to respond to one question about the likelihood of allowing their child to participate in a clinical trial (i.e., If your child were asked to be in a clinical trial, how likely would you be to let them participate?; 1 = Not likely at all; 2 = Not very likely; 3 = Not sure; 4 = Likely; 5 = Very likely). Responses will be averaged and the minimum scale score is 1 and the maximum scale score is 5. Higher scores indicate greater likelihood of allowing child to participate in a clinical trial.

Time frame: Baseline and Week 1

Population: The discrepancy between the overall number of participants analyzed and participant flow is due to imputation. Demographic variables were not imputed so if a participant was missing demographic data, they were not included in the outcome analyses.

Parents will be asked to respond to 16 questions regarding their perceptions of the quality of communication with their adolescent (If my child were in trouble, she/he could tell me; 1 = Strongly Disagree, 2 = Disagree; 3 = Agree; 4 = Strongly Agree). Responses will be averaged and the minimum scale score is 1 and the maximum scale score is 4. Higher scores indicate more positive perceptions of relationship quality.

Time frame: Baseline and Week 1

Population: The discrepancy between the overall number of participants analyzed and participant flow is due to imputation. Demographic variables were not imputed so if a participant was missing demographic data, they were not included in the outcome analyses.

Parents will review five research protocols related to a fictitious disease ('meditis') and respond to questions about their willingness to let their child participate in each research study (i.e., If your child had meditis, would you agree to enroll them in this study?; 1 = Definitely not to 7 = Definitely yes). Responses will be averaged across the five protocols and the minimum scale score is 1 and the maximum scale score is 7. Higher scores indicate greater willingness to allow their child to participate in the research studies.

Time frame: Baseline and Week 1

Population: The discrepancy between the overall number of participants analyzed and participant flow is due to imputation. Demographic variables were not imputed so if a participant was missing demographic data, they were not included in the outcome analyses.